RIPK1 and neurodegenerative disease: The activation of RIPK1 has also been implicated in mediating inflammatory responses in neurodegenerative diseases such as amyotrophic lateral sclerosis (ALS), multiple sclerosis (MS) and Alzheimer’s disease.